â– LECTURE OVERVIEW: Nephrotic Syndrome represents a severe pattern of glomerular injury characterized by a dramatic increase in glomerular capillary wall permeability to plasma proteins.
â– PATHOPHYSIOLOGIC MECHANISMS:
1. Podocyte Foot Process Effacement: Glomerular basement membrane filtration barriers are disrupted, commonly due to podocyte injury or antigen complex deposition.
2. Massive Proteinuria: Loss of negative charge barriers causes massive, heavy proteinuria (>3.5 grams/24 hours).
3. Hypoalbuminemia: Hepatic protein synthesis cannot compensate for renal losses, dropping serum albumin below 3 g/dL.
4. Oncotic Pressure Loss: Lower intravascular oncotic pressure shifts fluid into the interstitium, triggering compensatory sodium retention that causes generalized edema (anasarca).
5. Hyperlipidemia: In response to hypoalbuminemia, the liver non-specifically upregulates lipoprotein synthesis, leading to hyperlipidemia and lipiduri (visible on microscopy as 'fatty casts' and maltese-cross lipid droplets).
â– THERAPEUTIC TARGETS & MANAGEMENT:
Primary pharmacological intervention aims to restore physiological homeostatic balance. This is achieved by either competitively blocking receptor sites, allosterically inhibiting enzymes, or supplementing missing metabolic products.
â– CLINICAL REGISTRY INSIGHTS:
Patient registry reviews depict high clinical validity in diverse populations, indicating highly correlated trends of symptom development and treatment responsiveness.
[HY-BOARD-1004]
🌟 Dynamic Clinical Key:
Urinary protein wasting is not limited to albumin. Wasting of Antithrombin-III (ATIII) creates a hypercoagulable state that carries a high risk of thromboembolism, particularly renal vein thrombosis, which presents as sudden flank pain and hematuria. Absolute contraindications include pregnancy, renal insufficiency, or concurrent use of metabolic inhibitors. Assess demographic representation when applying trial results to real-world patients.